Famaro SA
Famaro reported total assets of €1.18m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Famaro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +42 % Total assets +21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Famaro's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 18 Jun 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Famaro's financial analysis
- Solvency89.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Famaro
Famaro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0442.357.018
- VAT number
- BE0442357018
- Peppol
- Registered · 0208:0442357018 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Oct 1990
- Registered office
- 3700 Tongeren-Borgloon
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Famaro (SA) has been based in Tongeren-Borgloon since 1990, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 155,121 € and equity of €1.05m; its revenue is not published. Its solvency stands at 89.3%, above the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Famaro
Companies in the same business, of comparable size and area, outside its group.
- Filepharma Invest Activities of head offices Soignies · balance sheet €1.10m
- Ardal Pharma Business and other management consultancy activities Jette · balance sheet €1.22m
- RED One Pharma Retail sale of pharmaceutical products Brussels · balance sheet €1.19m
- Sodyss Retail sale of pharmaceutical products Diest · balance sheet €1.02m
- Pharmacie des Saules Retail sale of pharmaceutical products Frameries · balance sheet €1.84m
- Apotheek Vandromme Retail sale of pharmaceutical products Wevelgem · balance sheet €1.35m
- VVD SRL Retail sale of pharmaceutical products Ixelles · balance sheet 956,770 €
- Prieels Pharma Retail sale of pharmaceutical products Oud-Heverlee · balance sheet €1.29m
Frequently asked questions about Famaro
What is the revenue of Famaro?
Famaro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Famaro?
In Belgium, the VAT number is the company number prefixed with BE: BE0442357018 for Famaro, if the company is VAT-registered. Its company number (CBE) is 0442.357.018.
Where is the registered office of Famaro?
According to the CBE register, the registered office of Famaro is in 3700 Tongeren-Borgloon.
What is the equity of Famaro?
At the close of the 2025 financial year, the equity of Famaro amounts to 1,051,909 €, a solvency of 89.3% of total assets.
Who manages Famaro?
The register lists 3 active mandates at Famaro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Famaro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →